These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2218417

  • 1. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K.
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R, Griggs D, Andrews JM.
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [Abstract] [Full Text] [Related]

  • 3. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG, Mutlu I, Ozyazgan S, Gök A, Yigit U, Ozüner Z, Senses V, Pekel H.
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [Abstract] [Full Text] [Related]

  • 4. In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Obana Y, Nishino T.
    Drugs Exp Clin Res; 1989 May; 15(2):53-8. PubMed ID: 2661182
    [Abstract] [Full Text] [Related]

  • 5. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG.
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [Abstract] [Full Text] [Related]

  • 6. The comparative pharmacokinetics of five quinolones.
    Wise R, Lister D, McNulty CA, Griggs D, Andrews JM.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [Abstract] [Full Text] [Related]

  • 7. Quinolone pharmacokinetics and metabolism.
    Lode H, Höffken G, Boeckk M, Deppermann N, Borner K, Koeppe P.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [Abstract] [Full Text] [Related]

  • 8. Penetrability of ofloxacin into cultured epithelial cells and macrophages.
    Une T, Osada Y.
    Arzneimittelforschung; 1988 Sep; 38(9):1265-7. PubMed ID: 3066365
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of ciprofloxacin with reference to other fluorinated quinolones.
    Bergan T.
    J Chemother; 1989 Feb; 1(1):10-7. PubMed ID: 2542469
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP, Leroy A, Moulin B, Dhib M, Borsa-Lebas F, Humbert G.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213
    [Abstract] [Full Text] [Related]

  • 11. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humours of patients by different topical application modes.
    von Keyserlingk J, Beck R, Fischer U, Hehl EM, Guthoff R, Drewelow B.
    Eur J Clin Pharmacol; 1997 Oct; 53(3-4):251-5. PubMed ID: 9476040
    [Abstract] [Full Text] [Related]

  • 12. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor using different topical application modes.
    Beck R, van Keyserlingk J, Fischer U, Guthoff R, Drewelow B.
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):89-92. PubMed ID: 9987622
    [Abstract] [Full Text] [Related]

  • 13. Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor.
    Donnenfeld ED, Schrier A, Perry HD, Aulicino T, Gombert ME, Snyder R.
    Ophthalmology; 1994 May; 101(5):902-5. PubMed ID: 8190478
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of enoxacin, ofloxacin, and norfloxacin concentration in human benign prostatic tissue].
    Yasumoto R, Asakawa M.
    Hinyokika Kiyo; 1988 Aug; 34(8):1519-21. PubMed ID: 3195414
    [Abstract] [Full Text] [Related]

  • 15. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
    Zeiler HJ, Beermann D, Wingender W, Förster D, Schacht P.
    Infection; 1988 Aug; 16 Suppl 1():S19-23. PubMed ID: 3286510
    [Abstract] [Full Text] [Related]

  • 16. Comparative pharmacokinetics of ofloxacin and ciprofloxacin.
    Wolfson JS, Hooper DC.
    Am J Med; 1989 Dec 29; 87(6C):31S-36S. PubMed ID: 2690617
    [Abstract] [Full Text] [Related]

  • 17. Ofloxacin in urinary tract infections.
    Kromann-Andersen B, Krøyer Nielsen K.
    Scand J Infect Dis Suppl; 1990 Dec 29; 68():35-40. PubMed ID: 2218420
    [Abstract] [Full Text] [Related]

  • 18. [Effect of ofloxacin, ciprofloxacin and nalidixic acid on serum theophylline level in patients treated with methylxanthine preparations].
    Chyrek-Borowska S, Siergiejko Z, Michalska I, Szymański W.
    Pneumonol Alergol Pol; 1992 Dec 29; 60(1-2):36-9. PubMed ID: 1290977
    [Abstract] [Full Text] [Related]

  • 19. The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
    Melby K, Faegri A.
    APMIS; 1989 Apr 29; 97(4):347-50. PubMed ID: 2497756
    [Abstract] [Full Text] [Related]

  • 20. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials.
    Nix DE, DeVito JM.
    Clin Pharm; 1987 Feb 29; 6(2):105-17. PubMed ID: 3311572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.